MUA's Efficacy in Frozen Shoulder in Patients Which Already Received an Hidrodilatation
Frozen Shoulder
About this trial
This is an interventional treatment trial for Frozen Shoulder
Eligibility Criteria
Inclusion Criteria:
- Patient with "frozen shoulder", defined as painful shoulder accompanied with a greater or lesser degree of restriction of mobility, especially in passive external rotation of at least 3 months of evolution. The diagnosis, according to the usual protocol of the unit, should include radiological images that rule out degenerative or necrotic pathology and the performance of an ultrasound or MRI to rule out associated pathology of the rotator cuff, which are already obtained in the usual clinical follow-up.
- Failure of conservative treatment after a period of 3 months.
- Acceptance and signature of informed consent.
Exclusion Criteria:
- Known allergies to corticosteroids
- Patients with frozen shoulder secondary to previous shoulder surgery.
- High-risk patients in need of anticoagulant treatments.
- Patients with previous shoulder fracture.
- History of joint infection.
- Active neoplastic process.
- Associated rheumatic pathology.
Sites / Locations
- Hospital Clínic
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Hidro alone
Hidro + MUA
The patient receives the Hidrodilatation guided by ultrasonography under anesthetic blockage of the circumflex nerve and the supraescapular nerve. The hidrodilatation is achieved by insuflating the articulation with 2 cc of trigon depot + 10 cc 1% mepivacain + 11 cc saline serum.
The patient receives the Hidrodilatation guided by ultrasonography under anesthetic blockage of the circumflex nerve and the supraescapular nerve. The hidrodilatation is achieved by insuflating the articulation with 2 cc of trigon depot + 10 cc 1% mepivacain + 11 cc saline serum. After the Hidrodilatation the patient is sedated and then a Movilization of the glenohumeral joint is performed.